Selective Estrogen Receptor Alpha Agonist GTx-758 Decreases Testosterone with Reduced Side Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer.

Publication Type:

Journal Article

Source:

European urology (2014)

Keywords:

2014, Clinical Research Division, July 2014

Abstract:

A need remains for new therapeutic approaches for men with advanced prostate cancer, particularly earlier in the disease course.